NCT07244081 Kinesiotherapy on Upper Limb Function and Activities of Daily Living in Children With Hemiplegic Cerebral Palsy
| NCT ID | NCT07244081 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Hemiplegic Cerebral Palsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 28 participants |
| Start Date | 2025-10-22 |
| Primary Completion | 2026-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 28 participants in total. It began in 2025-10-22 with a primary completion date of 2026-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will be randomized controlled trial, data will be collected from BASES special education school sialkot , Allama Iqbal Memorial Hospital, sialkot and Lahore. The study will include 28 patients equally divided into two groups and randomly allocated. Inclusion criteria for the study will be age of 8-13 years old of both sexes, ability to follow simple instructions, able to sit or stand with support to participate in physical therapy sessions( MACS level Ⅰ-Ⅲ) and (GMFCS level Ⅰ-Ⅲ), ability to communicate needs and discomfort (verbally or non-verbally), No concurrent participation in other physical therapy and excluded with Severe visual and hearing impairments, severe cognitive disabilities, History of seizures, Recent (within 6 months) or planned orthopedic surgery, Concurrent use of botulinum toxin injections. Experimental group will perform both Kinesiotherapy protocol and conventional physical therapy while Control group will perform only conventional physical therapy for 8 weeks 2-3 times weekly with 45 min of each session. Outcomes to be analyzed will be upper limb function and Activities of daily living (ADLs). Tools used for data collection will be Action Research Arm (ARA) test, Pediatric Evaluation of Disability Inventory (PEDI). Data will be analyzed through SPSS version 26, 27.
Eligibility Criteria
Inclusion Criteria: * Age: 8-13 years old both sexes * Ability to follow simple instructions, able to sit or stand with support to participate in physical therapy sessions( MACS level Ⅰ-Ⅲ)(9) and (GMFCS level Ⅰ-Ⅲ)(10) * Ability to communicate needs and discomfort (verbally or non-verbally) * No concurrent participation in other physical therapy or rehabilitation programs Exclusion Criteria: * Severe visual and hearing impairments that would hinder participation * Severe cognitive or intellectual disabilities that would impede understanding of instructions * History of seizures or other neurological conditions that may impact participation * Recent (within 6 months) or planned orthopedic surgery * Concurrent use of botulinum toxin injections or oral medications affecting muscle tone(2).
Contact & Investigator
Naima Andleeb, MS PT
PRINCIPAL INVESTIGATOR
Riphah Internatonal university
Frequently Asked Questions
Who can join the NCT07244081 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 13 Years, studying Hemiplegic Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07244081 currently recruiting?
Yes, NCT07244081 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07244081 trial being conducted?
This trial is being conducted at Sialkot, Pakistan.
Who is sponsoring the NCT07244081 clinical trial?
NCT07244081 is sponsored by Riphah International University. The principal investigator is Naima Andleeb, MS PT at Riphah Internatonal university. The trial plans to enroll 28 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.